A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.

Maglakelidze, Marina; ...; Andric, Zoran G; Nikolic, Ivan V; ...; Radosavljevic, Davorin Z; Petrovic, Zoran; ...; (broj, koautora 17)

Results

eNauka > Results > A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.

Title:	A Phase 1b/2 Open-Label Study with Randomization in Phase 2 of Imu-131 Her2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients with Her2/Neu Overexpressing Metastatic Or Advanced Adenocarcinoma of the Stomach Or Gastroesophageal Junction.
Authors:	Maglakelidze, Marina; ...; Andric, Zoran G ; Nikolic, Ivan V ; ...; Radosavljevic, Davorin Z ; Petrovic, Zoran; ...; (broj, koautora 17)
Issue Date:	2021
Publication:	CANCER RESEARCH
ISSN:	0008-5472 Cancer Research Search Idenfier
Type:	Conference Paper
Collation:	vol. 81 br. 13 str. CT107
WoS-ID:	000680263501246
URI:	https://enauka.gov.rs/handle/123456789/805596
Metadata source:	(Preuzeto iz Nasi u WoS)
Note:	Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, APR 10-MAY 21, 2021
M-category:	Mp. category will be shown later

2
WEB OF SCIENCE^TM

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM